Axovant (AXGT) Prices 14.03M Share Common Offering at $3.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
After-Hours Stock Movers 02/19: (STMP) (ZG) (CAR) Higher (TVTY) (OSUR) (AXGT) Lower (more...)
February 19, 2020 5:43 PM ESTToday's After-Hours Stock Movers
Tivity Health, Inc. (NASDAQ: TVTY) 32.4% LOWER; reported Q4 EPS of $0.40, $0.15 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $272.8 million versus the consensus estimate of $275.15 million. Tivity Health, Inc. sees Q1 2020 revenue of $335-350 million, versus the consensus of $363.4 million. Tivity Health, Inc. sees FY2020 revenue of $1.243-1.285 billion, versus the consensus of $1.34 billion. Tivity Health Announces Departure of CEO Donato J. Tramuto and Appoints Healthcare Veteran as Interim CEO
Axovant (AXGT) to Offer Common Stock
February 19, 2020 4:03 PM ESTAxovant Gene Therapies Ltd. (Nasdaq: AXGT) announced that it has commenced an underwritten public offering of its common shares and pre-funded warrants to purchase its common shares. In connection with this offering, Axovant expects to grant the underwriters a 30-day option to purchase... More



